Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.61% | 16.21% | 32.45% | -11.30% | -2.06% |
| Total Receivables | -55.56% | 28.57% | 16.67% | 20.00% | -16.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 257.53% | -42.83% | -35.35% | -26.65% | 276.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.48% | 20.86% | -24.25% | -10.71% | -68.98% |
| Total Current Assets | -20.42% | 13.16% | 22.84% | -13.12% | -2.83% |
|
|
|||||
| Total Current Assets | -20.42% | 13.16% | 22.84% | -13.12% | -2.83% |
| Net Property, Plant & Equipment | -10.73% | -9.69% | -6.67% | -10.45% | -10.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Assets | -9.74% | 5.59% | 8.71% | -5.74% | 2.76% |
|
|
|||||
| Total Accounts Payable | -5.18% | 30.39% | 65.78% | -43.13% | 37.51% |
| Total Accrued Expenses | 48.78% | 1.18% | -6.55% | -15.50% | -0.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.84% | 2.92% | 3.79% | 3.13% | 3.23% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.97% | 16.17% | 20.63% | -28.19% | 14.75% |
|
|
|||||
| Total Current Liabilities | 16.97% | 16.17% | 20.63% | -28.19% | 14.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.54% | -16.67% | -13.95% | -11.64% | -10.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.21% | -25.00% | -99.89% | 101.10% | 49.49% |
| Total Liabilities | 16.14% | 14.89% | -84.94% | 64.38% | 37.13% |
|
|
|||||
| Common Stock & APIC | 1.73% | 5.92% | 13.52% | 21.44% | 0.27% |
| Retained Earnings | -3.49% | -6.24% | 7.02% | -32.32% | -4.78% |
| Treasury Stock & Other | -23.08% | -620.00% | 122.73% | -15.79% | 0.00% |
| Total Common Equity | -23.68% | 1.18% | 155.74% | -275.72% | -17,159.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.68% | 1.18% | 155.74% | -275.72% | -17,159.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.68% | 1.18% | 155.74% | -275.72% | -17,159.52% |
|
|
|||||